EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

m6A RNA modification: a central epitranscriptomic switch orchestrating oncogenic signaling and glycolytic reprogramming in cancer

Yonggang Guo, Ruilong Kou, Zhizhong Huang, Zhihua Chen, Heng Yun

Frontiers in Cell and Developmental Biology · 03.07.2026 · 14

DOI: 10.3389/fcell.2026.1864321 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 03.07.2026. Verfasst von Yonggang Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pingdingshan University, Pingdingshan, China. Die Arbeit nennt 452 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N6-methyladenosine (m6A) is the most widespread, abundant, and conserved post-transcriptional modification in eukaryotic RNA, and it participates in the regulation of various biological processes, especially playing a crucial role in tumorigenesis and progression. During tumor progression, abnormal expression of m6A regulatory proteins often leads to dysregulation of m6A modification levels, thereby affecting tumor pathophysiology. Recent studies have shown that in various tumor types, m6A modifications on target mRNAs and non-coding RNA transcripts can regulate the activity of various oncogenic signaling pathways; moreover, m6A modifications can also regulate the tumor glycolysis process through multiple molecular mechanisms, thereby affecting the proliferation, invasion, and metastasis of tumor cells and other biological behaviors. Most existing reviews focus only on the unidirectional regulatory relationships among m6A modification, oncogenic signaling, and glycolysis, while overlooking the crosstalk among the three. To address this gap, this review systematically summarizes the regulatory effects of m6A modifications on key glycolytic enzymes and various cancer signaling pathways, examines in depth the molecular mechanisms by which the three cooperatively participate in tumorigenesis and progression, comprehensively dissects the bidirectional crosstalk among the three core functional modules within this network, and further proposes a self-stabilizing “m6A–signaling–glycolysis closed-loop regulatory network,” and provides future research directions for this field. It offers theoretical references for related basic research and clinical diagnosis and treatment.

Schlagwörter

Stichwörter der Autor:innen

M6Aepitranscriptomicsglycolysissignaling pathwaytumor

Autor:innen und Institutionen

  • Pingdingshan University, Pingdingshan, China.
  • Department of Gastrointestinal Surgery, Affiliated Hospital of Guilin Medical University, Guilin, China.
  • School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
  • Department of Gastrointestinal Surgery II, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Department of General Surgery, The Third Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Baiyin, China.

Zitieren

APA

Guo, Y., Kou, R., Huang, Z., Chen, Z., & Yun, H. (2026). m6A RNA modification: a central epitranscriptomic switch orchestrating oncogenic signaling and glycolytic reprogramming in cancer. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1864321

Vancouver

Guo Y, Kou R, Huang Z, Chen Z, Yun H. m6A RNA modification: a central epitranscriptomic switch orchestrating oncogenic signaling and glycolytic reprogramming in cancer. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1864321

BibTeX
@article{Guo2026,
  author = {Guo, Yonggang and Kou, Ruilong and Huang, Zhizhong and Chen, Zhihua and Yun, Heng},
  title = {m6A RNA modification: a central epitranscriptomic switch orchestrating oncogenic signaling and glycolytic reprogramming in cancer},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1864321}
}
Kostenlos starten →